Polyhedral Oligomeric Silsesquioxane Based Catalyst for the Efficient Synthesis of Cyclic Carbonates

In this work, the synthesis of a novel imidazolium-based polyhedral oligomeric silsesquioxane (POSS-mim-Cl) material is presented. The new nanometer-size organosilica based compound was employed for chemical fixation of CO2 into epoxide under homogeneous conditions. The target reaction was represented by the obtention of cyclic carbonates starting from epoxides and CO2. Particularly, styrene oxide was chosen as reference substrate. In addition, different parameters (solvent, temperature, pressure of CO2, and mass of the catalyst) were modified to find the best condition for CO2 conversion. The catalyst POSS-mim-Cl displayed good catalytic performances, the best results being obtained at 40 bar of CO2, 150\ub0C, with 110 mg of catalyst and using isopropanol as co-solvent. It is worth to mention that POSS-mim-Cl displayed better catalytic performance than the corresponding 1-butyl-3-methyl imidazolium chloride. As far as we know this study represents the first use of imidazolium-based POSS as catalysts for the chemical fixation of CO2

Efficacy of pharmacological and mechanical cervical priming methods for induction of labour and their applicability for outpatient management: A systematic review of randomised controlled trials

A systematic review to determine the efficacy and safety of prostaglandins (PG) and Foley catheter (FC) for cervical priming in the outpatient setting. Various methods are available to achieve cervical ripening prior to induction of labour (IOL). In this systematic review, we will report the literature to date, and investigate the efficacy and safety of using the Foley catheter balloon or prostaglandins for cervical ripening, comparing both methods with each other, and discuss the implications of these findings for midwifery led units. English peer-reviewed journals were systematically searched in the databases PubMed, MEDLINE, EMCARE, EMBASE and CINAHL, for studies investigating cervical ripening using the FC or PGs. Additional randomised controlled trials (RCTs) and non-RCTs were identified by a manual search. Search terms included: cervix dilatation effacement, cervix ripening, outpatient, ambulatory care, obstetric patients, pharmacological preparations, and Foley catheter. Only RCTs of FC versus PG or either intervention versus placebo or intervention in the in-patient Vs. outpatient setting were included. 15 RCTs were included. The results of this review show that both FC and PG analogues are equally effective cervical ripening agents. When compared to FC, PGs lead to a reduced requirement for oxytocin augmentation and a shorter intervention to delivery interval. However, PG use is also associated with an increased risk of hyperstimulation, cardiotocographic monitoring abnormalities and negative neonatal outcomes. FC cervical ripening is an effective method of outpatient cervical priming, which is safe, acceptable, and cost-effective and thus has a potential role in both resource-rich and resource-poor countries. With appropriate dosing, some PG analogues also appear to offer similar outcomes. [Abstract copyright: Copyright © 2023 Elsevier B.V. All rights reserved.

In Vivo Biodistribution of Amino-Functionalized Ceria Nanoparticles in Rats Using Positron Emission Tomography

A variety of nanoparticles have been proposed for several biomedical applications. To gauge the therapeutic potential of these nanoparticles, in vivo biodistribution is essential and mandatory. In the present study, ceria nanoparticles (5 nm average particle size) were labeled with ¹⁸F to study their in vivo biodistribution in rats by positron emission tomography (PET). The ¹⁸F isotope was anchored by reaction of <i>N</i>-succinimidyl 4-[¹⁸F]­fluorobenzoate (¹⁸F-SFB) with a modified nanoparticle surface obtained by silylation with 3-aminopropylsilyl. Radiolabeled ceria nanoparticles accumulated mainly in lungs, spleen, and liver. Metabolic products of the radiolabeled nanoparticulate material were excreted into the urinary tract

Natural alginate as a graphene precursor and template in the synthesis of nanoparticulate ceria/graphene water oxidation photocatalysts

Using alginate, a natural polysaccharide from algae, simultaneously as a graphene precursor and a templating agent for ceria nanoparticles, we have prepared a series of materials consisting of highly crystalline ceria nanoparticles embedded on a few-layer graphene matrix. XPS analysis indicates that the predominant oxidation state of Ce in the as-synthesized CeOx/graphene material is +III (over 80 atom %). Varying the weight percentage of ceria/alginate and the pyrolysis temperature enabled the preparation of a ceria/graphene photocatalyst that exhibits about 3 times higher photocatalytic activity for water oxidation to oxygen than commercial ceria. Our results on the ceria/graphene composite as a photocatalyst for water oxidation expand and complement the well-known effect of graphene to increase the photocatalytic efficiency of titania/ graphene composites.Financial support by the Spanish Ministry of Economy and Competitiviness (CTQ-2012-3532 and Severo Ochoa) is gratefully acknowledged. The Generalitat Valenciana is also thanked for financial support (Prometeo). A.P. thanks the Spanish CSIC for a research associate contract (JAE-Doc). C.L. thanks the European Commission, the European Social Fund, and the Regione Calabria for financial support of her Ph.D. fellowship and funding for her stay in Valencia.Lavorato, C.; Primo Arnau, AM.; Molinari, R.; García Gómez, H. (2014). Natural alginate as a graphene precursor and template in the synthesis of nanoparticulate ceria/graphene water oxidation photocatalysts. ACS Catalysis. 4(2):497-504. doi:10.1021/cs401068mS4975044

In Vivo Biodistribution of Amino-Functionalized Ceria Nanoparticles in Rats Using Positron Emission Tomography

A variety of nanoparticles have been proposed for several biomedical applications. To gauge the therapeutic potential of these nanoparticles, in vivo biodistribution is essential and mandatory. In the present study, ceria nanoparticles (5 nm average particle size) were labeled with F-18 to study their in vivo biodistribution in rats by positron emission tomography (PET). The F-18 isotope was anchored by reaction of N-succinimidyl 4-[F-18]fluorobenzoate (F-18-SFB) with a modified nanoparticle surface obtained by silylation with 3-aminopropylsilyl. Radiolabeled ceria nanoparticles accumulated mainly in lungs, spleen, and liver. Metabolic products of the radiolabeled nanoparticulate material were excreted into the urinary tract.The present work was supported by the Spanish MICINN (Grants CTQ-2009-11586, CTQ2006-06785, and CTQ2007-67805-AR07, PI10/1195, AP192/11); the Fondo de Investigacion Sanitaria (FIS) of the Instituto de Salud Carlos III (Grants PS09/02620, PI10/1195, and PS09/02217), the Generalitat Valenciana (Grant ACOMP/2012/045), La Marato Fundation (Grant 090530), and by CDTI under the CENIT Programme (AMIT Project) and the Spanish Ministry of Science and Innovation. V.M.V. is a recipient of a contract from the Regional Ministry of Health of the Valencian Regional Government and Carlos III Health Institute (CES10/030).Rojas, S.; Domingo Gispert, J.; Abad Fuentes, S.; Buaki-Sogo, M.; Victor, VM.; García Gómez, H.; Herance Camacho, JR. (2012). In Vivo Biodistribution of Amino-Functionalized Ceria Nanoparticles in Rats Using Positron Emission Tomography. Molecular Pharmaceutics. 9(12):3543-3550. https://doi.org/10.1021/mp300382nS3543355091